IRX2 and IRX3 are also oncogenic members of the TALE-class of homeobox genes, deregulating hematopoietic TFs including TCF3 and ETV6, respectively, and activating corresponding oncogenic fusion genes in BCP-ALL [7,23]. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.